These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10641793)

  • 21. Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Xu YX; Wang H; Li XK; Dong SN; Liu WW; Gong Q; Wang TD; Tang Y; Zhu J; Li J; Zhang HY; Mao F
    Eur J Med Chem; 2018 Jan; 143():33-47. PubMed ID: 29172081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are Terminal Alkynes Necessary for MAO-A/MAO-B Inhibition? A New Scaffold Is Revealed.
    Mavroeidi P; Zorba LP; Tzouras NV; Neofotistos SP; Georgiou N; Sahin K; Şentürk M; Durdagi S; Vougioukalakis GC; Mavromoustakos T
    Molecules; 2024 May; 29(11):. PubMed ID: 38893361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors.
    Pozdnev VF; Kirkel AZ; Kamyshanskaya NS; Axenova LN; Medvedev AE
    J Neural Transm Suppl; 1998; 52():351-5. PubMed ID: 9564638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycyclic propargylamine and acetylene derivatives as multifunctional neuroprotective agents.
    Zindo FT; Barber QR; Joubert J; Bergh JJ; Petzer JP; Malan SF
    Eur J Med Chem; 2014 Jun; 80():122-34. PubMed ID: 24769350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of monoamine oxidase B by aminoethyl substituted benzyl ethers.
    Woodroofe CC; Mostashari R; Lu X; Ramsay RR; Silverman RB
    J Enzyme Inhib; 2000; 15(1):11-21. PubMed ID: 10850952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase.
    Meiring L; Petzer JP; Legoabe LJ; Petzer A
    Bioorg Med Chem Lett; 2022 Jul; 67():128746. PubMed ID: 35447344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine.
    Dyck LE; Davis BA
    Drug Metab Dispos; 2001 Aug; 29(8):1156-61. PubMed ID: 11454735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of monoamine oxidase by clorgyline analogues.
    O'Brien EM; Tipton KF; Meroni M; Dostert P
    J Neural Transm Suppl; 1994; 41():295-305. PubMed ID: 7931241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 35. Histamine N-methyltransferase: inhibition by monoamine oxidase inhibitors.
    Boudíková-Girard B; Scott MC; Weinshilboum R
    Agents Actions; 1993 Sep; 40(1-2):1-10. PubMed ID: 8147263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural comparison of human monoamine oxidases A and B: mass spectrometry monitoring of cysteine reactivities.
    Hubalek F; Pohl J; Edmondson DE
    J Biol Chem; 2003 Aug; 278(31):28612-8. PubMed ID: 12777388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
    Huleatt PB; Khoo ML; Chua YY; Tan TW; Liew RS; Balogh B; Deme R; Gölöncsér F; Magyar K; Sheela DP; Ho HK; Sperlágh B; Mátyus P; Chai CL
    J Med Chem; 2015 Feb; 58(3):1400-19. PubMed ID: 25627172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.